Cardiome Pharma Corp (NASDAQ:CRME)

9.93
Delayed Data
As of Mar 02
 +0.15 / +1.53%
Today’s Change
5.84
Today|||52-Week Range
11.31
+7.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues3.9M7.6M7.7M7.8M
 
 
 
 
 
Cost of Goods Sold889.0K1.5M2.2M2.7M
 
 
 
 
 
Depreciation And Amortization325.0K536.0K564.0K510.0K
 
 
 
 
 
 
Operating ExpensesGross Income2.7M5.6M4.9M4.6M
 
 
 
 
 
General Expenses7.3M8.2M8.9M8.1M
 
 
 
 
 
Research And Development40.0K245.0K59.0K234.0K
 
 
 
 
 
Total Operating Expenses8.5M10.3M11.7M11.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.7M-2.7M-4.0M-3.5M
 
 
 
 
 
Extraordinary Charge-2.8M0.000.000.00
 
 
Interest Expense On Debt121.0K254.0K226.0K495.0K
 
 
 
 
 
Other Expenses491.0K-82.0K149.0K-285.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.1M-3.0M-4.1M-4.3M
 
 
 
 
 
Income Taxes-102.0K-117.0K-156.0K-114.0K
 
 
 
 
 
Net Income-7.2M-3.1M-4.2M-4.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.7M15.3M16.5M16.5M
 
 
 
 
 
Shares To Calculate EPS Diluted13.7M15.3M16.5M16.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.53-$0.20-$0.26-$0.26
 
 
 
 
 
EPS Diluted-$0.53-$0.20-$0.26-$0.26
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account